Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of rosiglitazone and sulphonylureas on ischaemic burden, blood pressure, and novel risk markers inclusive of vascular function in patients with chronic stable angina and type 2 diabetes mellitus: a randomised, double-blinded st...

Trial Profile

Effects of rosiglitazone and sulphonylureas on ischaemic burden, blood pressure, and novel risk markers inclusive of vascular function in patients with chronic stable angina and type 2 diabetes mellitus: a randomised, double-blinded st...

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Feb 2010

At a glance

  • Drugs Rosiglitazone; Sulfonylureas
  • Indications Angina pectoris; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Jul 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top